Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-flow Nasal Therapy for Early Management of Hypercapnic Respiratory Failure Due to Acute Cardiogenic Pulmonary Edema in the ED: a Prospective Observational Study

NCT03883555 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03883555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03883555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-flow Nasal Therapy for Early Management of Hypercapnic Respiratory Failure Due to Acute Cardiogenic Pulmonary Edema in the ED: a Prospective Observational Study
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
February 1, 2015
Completion date
September 30, 2016
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute cardiogenic pulmonary edema, hypercapnic respiratory failure